TCA
DXCM icon

Transcend Capital Advisors’s DexCom DXCM Stock Holding History

Transcend Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,511
Closed -$398K – 625
2024
Q2 		$398K Sell
3,511
-12
-0.3% -$1.52K 0.03% 403
2024
Q1 		$489K Buy
+3,523
New +$443K 0.04% 327

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Transcend Capital Advisors's DXCM Position: Q3 2024 in Review

Transcend Capital Advisors sold out of DexCom (DXCM) in Q3 2024, closing a stake of 3,511 shares — an estimated $398K sold.

Transcend Capital Advisors first reported a position in DXCM in Q1 2024 and held it in 2 quarters. The position peaked at $489K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Transcend Capital Advisors reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Transcend Capital Advisors sold 3,511 DexCom shares in Q3 2024, an estimated $398K.
  • Transcend Capital Advisors first reported a position in DexCom in Q1 2024 and held it in 2 quarters.
  • Transcend Capital Advisors's DexCom position peaked at $489K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Transcend Capital Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.